Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study - Concepedia

Concepedia

Publication | Closed Access

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

109

Citations

17

References

2015

Year

Giovanni Martinelli, Vivian G. Oehler, Cristina Papayannidis, Rachel Courtney, M. Naveed Shaik, Xiaoxi Zhang, Ashleigh O’Connell, Karen R. McLachlan, Xianxian Zheng, Jerald P. Radich,

The Lancet Haematology

Hematological MalignancyOncologyOral Smoothened AntagonistMedicineMalignant Blood DisorderHematologyPharmacokinetics StudyPharmacotherapyPharmacologyPhase 1Cancer ResearchMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1